
News|Articles|October 1, 2008
Formulary Digital Edition October 2008
Rational approaches to the treatment of mixed dyslipidemia; Focus on eltrombopag; Drug Watch: Agents in late-stage development for the treatment of hepatitis B and C virus infections
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Gilead’s Single-Tablet HIV Regimen Meets Primary Endpoints
2
COVID-19 vaccines could help tumors respond better to immune checkpoint inhibitors
3
Keytruda shows survival edge over Tecentriq, Opdivo in older patients with lung cancer
4
Integrin beta-6 emerges as a novel biomarker for NSCLC
5


















































